论文部分内容阅读
目的探讨治疗慢性支气管炎革兰阴性菌感染的有效方案。方法选取2011年3月至2013年5月我院收治的147例慢性支气管炎革兰阴性菌感染患者作为研究对象,根据治疗方案将其分为两组,研究组患者接受头孢哌酮/舒巴坦治疗,对照组患者接受头孢他啶治疗,对比分析两组患者的治疗效果。结果研究组患者细菌清除率为90.6%,明显高于对照组的69.4%,差异有统计学意义(P<0.05);研究组治疗效果明显优于对照组,两组比较差异有统计学意义(P<0.05);两组患者总不良反应发生率比较差异无统计学意义(P>0.05)。结论头孢哌酮/舒巴坦治疗慢性支气管炎革兰阴性菌感染细菌清除率高、临床疗效确切、安全性好。
Objective To investigate the effective treatment of chronic bronchitis Gram-negative bacteria infection. Methods From March 2011 to May 2013 in our hospital, 147 cases of chronic bronchitis patients with Gram-negative bacterial infections were selected as study subjects, which were divided into two groups according to the treatment plan. The patients in study group received cefoperazone / Tan treatment, the control group received ceftazidime treatment, comparative analysis of the treatment effect of two groups of patients. Results The bacterial clearance rate in the study group was 90.6%, which was significantly higher than that in the control group (69.4%) (P <0.05). The treatment effect of the study group was significantly better than that of the control group, with significant difference between the two groups P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion Cefoperazone / sulbactam treatment of chronic bronchitis Gram-negative bacterial infection rate of bacterial clearance, clinical curative effect is exact, good safety.